Clinical Trial Update: Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the safety and efficacy of azacitidine in combination with lenalidomide in patients with higher-risk myelodysplastic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Revlimid (lenalidomide)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: UNKNOWN